Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Healthcare Triangle (HCTI) Amortization of Deferred Charges (2024)

Healthcare Triangle's Amortization of Deferred Charges history spans 1 years, with the latest figure at $762000.0 for Q4 2024.

On a quarterly basis, Amortization of Deferred Charges changed N/A to $762000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was $943000.0, a 3.68% decrease, with the full-year FY2025 number at $223000.0, down 77.22% from a year prior.
Amortization of Deferred Charges hit $762000.0 in Q4 2024 for Healthcare Triangle, up from $72000.0 in the prior quarter.
Over the last five years, Amortization of Deferred Charges for HCTI hit a ceiling of $762000.0 in Q4 2024 and a floor of $36000.0 in Q1 2024.